AI Article Synopsis

  • Sinus of Valsalva aneurysm (SOVA) is a rare condition often linked to progressive aortic dilation.
  • An adolescent boy with DiGeorge syndrome showed signs of fever and a wide pulse pressure, which made it seem like he had endocarditis.
  • The use of echocardiography helped in quickly diagnosing a ruptured SOVA, emphasizing the importance of checking for this rare condition in patients with similar high-risk backgrounds.

Article Abstract

Sinus of Valsalva aneurysm (SOVA) is rare and can occur in diseases with progressive aortic dilation. We report an adolescent male with DiGeorge syndrome who presented with fever and wide pulse pressure mimicking endocarditis. A timely diagnosis of ruptured SOVA using echocardiography enabled optimal treatment. Our case highlights the need to assess for this rare condition in this high-risk population.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011494PMC
http://dx.doi.org/10.4103/jcecho.jcecho_37_19DOI Listing

Publication Analysis

Top Keywords

sinus valsalva
8
valsalva aneurysm
8
digeorge syndrome
8
ruptured sinus
4
aneurysm mimicking
4
mimicking infective
4
infective endocarditis
4
endocarditis digeorge
4
syndrome sinus
4
aneurysm sova
4

Similar Publications

BACKGROUND A single coronary artery is a rare congenital anomaly of the coronary arteries distribution, with an incidence of only 0.03% in the general population undergoing coronary angiography. RCA arising from the distal circumflex artery is an extremely rare variety.

View Article and Find Full Text PDF

Trans-Coronary Sinus Intra-Septal Radiofrequency Ablation (TIRA) for Hypertrophic Obstructive Cardiomyopathy: First-in-Human Results.

Biomedicines

December 2024

Department of Internal Medicine, Pusan National University School of Medicine and Cardiology, Cardiovascular Center and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan 50612, Republic of Korea.

Background: Current treatments for hypertrophic obstructive cardiomyopathy (HOCM), including medication, surgery, and alcohol septal ablation (ASA), have limitations in terms of efficacy and safety. To address these challenges, we developed the trans-coronary intra-septal radiofrequency ablation (TIRA) device.

Methods: This first-in-human trial was conducted to assess the efficacy and safety of the TIRA device.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!